Mark Rothera
Chief Executive Officer at VIRACTA THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Frank Thomas | M | 54 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 years |
Craig Tooman | M | 58 | 3 years | |
Ivor Royston | M | 79 | 17 years | |
Roger Pomerantz | M | 67 | 4 years | |
Melody Burcar | F | 41 | 2 years | |
Karim Smaira | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 years |
Jon Ellis | M | 57 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
Joanne Beck | M | 63 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
Simone Song | F | 59 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 years |
James Geraghty | M | 69 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
Jane Barlow | M | 63 | 3 years | |
Glenn Steele | M | 79 | 9 years | |
Jane Chung | F | 53 | 2 years | |
Eric Pauwels | M | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 15 years |
Kamel Ghammachi | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 years |
Sam Murphy | M | 47 | 5 years | |
Stephen Rubino | M | 65 | 3 years | |
Rhonda L. Hellums | F | 52 | 3 years | |
Charles Rowland | M | 65 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
Marc Dunoyer | M | 71 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 years |
Barry Simon | M | 59 | 3 years | |
Flavia Borellini | M | 65 | 3 years | |
Bobby Gaspar | M | 60 |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 years |
Ashleigh Barreto | F | - | 3 years | |
Martin Rexroad | M | - | 11 years | |
Thomas Darcy | M | 74 | 3 years | |
Biljana Nadjsombati | F | - | 3 years | |
Donald Strickland | M | - | - | |
Darrel Cohen | M | 59 | 1 years | |
Ashkar Samy | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
Michael Davidson | M | 67 | 3 years | |
Patric Nelson | M | - | 3 years | |
Ayman El-Guindy | M | - | 3 years | |
Elmar Schnee | M | 65 |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
Stewart M. Brown | M | - | 2 years | |
Cheryl A. Madsen | F | - | - | |
Murad Husain | M | - | 10 years | |
Curtis Rambaran | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel Chevallard | M | 44 | 5 years | |
Marcio Souza | M | 45 | 6 years | |
Ben Harshbarger | M | 55 | 4 years | |
Kurt J. W. Andrews | M | 54 | 9 years | |
John Curnutte | M | 72 | 5 years | |
Stephen J. Moloney | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 9 years |
Robert Quinn | M | 41 | 4 years | |
Cláudia Hirawat | F | 53 | 15 years | |
Emily Hill | F | 44 | - | |
Alexander Pasteur | M | 54 | - | |
William T. Andrews | M | 60 | 4 years | |
Dawn Svoronos | F | 70 | 6 years | |
Nicolas Koebel | M | - | - | |
Benjamin Auspitz | M | 51 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | - |
Steven Altschuler | M | 70 | 4 years | |
Adam Koppel | M | 54 | 4 years | |
Michael L. Kranda | M | 69 | 12 years | |
Alicia Secor | F | 62 | 6 years | |
Axel Bolte | M | 52 | 11 years | |
Ronald Renaud | M | 55 | 3 years | |
Shelly Vandertie | F | - | - | |
Elise T. Wang | F | 64 | - | |
Nicole Onetto | M | 71 | 2 years | |
Richard H. Aldrich | M | 69 | 2 years | |
Suzanne Bruhn | M | 60 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 14 years |
Megan Sniecinski | F | 43 | 5 years | |
Tu Yen Ong | M | 49 | - | |
Justine O'Malley | M | - | - | |
Alyssa Wyant | F | 49 | 2 years | |
Stephen Dilly | M | 64 |
CHIRON Biopharmaceuticals
| 3 years |
Jason Meyenburg | M | 47 | 1 years | |
Edward O'Mara | M | - | 4 years | |
Andrew Komjathy | M | 61 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 years |
Frank DeRosa | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 years |
Eric Fink | M | - | - | |
Sachiyo Minegishi | F | 46 | 4 years | |
Morgan Conn | M | 42 | 16 years | |
Anne Marie Conway | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 5 years |
Ran Zheng | F | 61 | 2 years | |
Nancy M. Wyant | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
Moya M. Daniels | F | 55 | 2 years | |
Adrian Haigh | M | 65 | 8 years | |
Sylvie Grégoire | M | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
Craig Wheeler | M | 63 |
CHIRON Biopharmaceuticals
| 5 years |
Paul Hastings | M | 64 |
CHIRON Biopharmaceuticals
| 10 years |
Stewart Craig | M | 63 | 3 years | |
Peter Svennilson | M | 62 | 2 years | |
Scott Wilhoit | M | 61 | 1 years | |
Deanna M. Petersen | F | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 years |
Robert Spiegel | M | 73 | 5 years | |
Susan E. Barrowcliffe | F | 66 |
CHIRON Biopharmaceuticals
| 2 years |
James G. Stout | M | 58 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 years |
Jay Barth | M | 60 | 5 years | |
Amanda Cray | F | - | 7 years | |
Lisa Rojkjaer | M | 58 | 3 years | |
Massimo Boriero | M | - | - | |
Daniel van Plew | M | 51 |
CHIRON Biopharmaceuticals
| 2 years |
Shane Kovacs | M | 50 | - | |
Theresa Heggie | F | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
R. Session | M | 45 | 4 years | |
Sue Cammarata | M | 67 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
Tom Luby | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 73 | 73.00% |
United Kingdom | 25 | 25.00% |
United Arab Emirates | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Rothera
- Personal Network